Again, you are wrong. The company has already publicized that it is advancing Brilacidin against Covid in a Phase 2 trial. That means humans, not animals. The reason (again) is that animal testing is primarily to determine safety. Efficacy results (positive or negative) for a particular drug in animals often does not translate to humans, so the “fruitless” testing would be if we did an animal trial. Thankfully, Leo is smart enough not to waste our money on “fruitless” animal testing.